Cellyan Biotechnology (HKPD) Intangibles (2024 - 2025)
Cellyan Biotechnology (HKPD) reported Intangibles of $90218.0 for Q3 2025, up 1.03% year-over-year from $89299.0 in Q3 2024, and down 6.45% quarter-over-quarter from $96437.0 in Q1 2025.
Cellyan Biotechnology (HKPD) Intangibles (2024 - 2025) Analysis & Trends
Cellyan Biotechnology (HKPD) has 2 years of Intangibles data on file, last reported at $90218.0 in Q3 2025.
- Intangibles for Q3 2025 came in at $90218.0, up 1.03% year-over-year; the trailing twelve-month figure through Sep 2025 was $90218.0 (up 1.03% YoY), and the FY2025 annual result was $96437.0, up 203.02% from the prior year.
- Intangibles retreated to $90218.0 in Q3 2025 per HKPD's latest filing, from $96437.0 in the prior quarter.
- Over five years, Intangibles peaked at $96437.0 in Q1 2025 and troughed at $31825.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 6.85 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 4.08 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 6.05 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 1.01 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 107.24 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 1.72 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 122,381.58 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 6.82 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 90,218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 90,218.00 |
| Mar 31, 2025 | 96,437.00 |
| Sep 30, 2024 | 89,299.00 |
| Mar 31, 2024 | 31,825.00 |